The Pregnancy and Postpartum Mental Health Optimization Virtual Intervention Network
MOVIN
1 other identifier
interventional
570
1 country
2
Brief Summary
Depression, anxiety, and related disorders such as post-traumatic stress and obsessive compulsive disorder affect about 20% of pregnant and postpartum people. When not treated properly, these issues negatively impact not only affected people, but also their children's health and development. Only 1 in 5 receive adequate treatment, so identifying new system-wide approaches to reliably deliver recommended care to perinatal mental health patients all is a crucial health care priority. The Pregnancy and Postpartum Mental health Optimization Virtual Intervention Network (MOVIN) is a scalable perinatal mental health platform building on the evidence-based Collaborative care delivery model. MOVIN's online platform allows patients to connect with a care coordinator to co-develop personalized treatment recommendations, in collaboration with their primary care clinician and a perinatal psychiatrist when needed; progress is tracked to re-evaluate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Oct 2025
Typical duration for not_applicable depression
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2025
CompletedFirst Posted
Study publicly available on registry
July 15, 2025
CompletedStudy Start
First participant enrolled
October 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2029
November 24, 2025
November 1, 2025
2.9 years
July 4, 2025
November 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Depressive symptoms
The primary objective of this trial is to determine the effect of MOVIN versus a control condition on perinatal depression symptoms. Depressive symptoms will be measured using the Edinburgh Postnatal Depressive Scale (EPDS), a self-report scale that has been validated for use in pregnancy and postpartum. EPDS scores range from 0 to 30.
24 weeks post randomization
Secondary Outcomes (13)
Maternal Remission of depression
24 weeks post randomization
Maternal Depressive symptoms
12 weeks post randomization
Maternal Depressive symptoms
12 and 24 weeks post randomization
Obsessive-Compulsive Inventory-Revised
12 and 24 weeks post randomization
Maternal Posttraumatic Stress Disorder Checklist
12 and 24 weeks post randomization
- +8 more secondary outcomes
Other Outcomes (1)
Clinician perspective survey
24 weeks post randomization
Study Arms (2)
Enhanced Usual Care
OTHERAccess to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.
MOVIN
EXPERIMENTALEnhanced Usual Care plus MOVIN Care Platform. The MOVIN Care Platform is virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.
Interventions
Access to online resources and educational materials about general mental health, maternal mental health, depression and anxiety in the pregnancy and postpartum period, and an up-to-date listing of treatment services available in Ontario. These resources are maintained by the MOVIN study team.
Virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.
Eligibility Criteria
You may qualify if:
- Adult (age 18 years or older)
- Pregnant or postpartum and living with their infant 0-6 months old. This includes all individuals who identify as women, as well as those of female sex who do not identify as women (e.g., non-binary, trans) who are the primary parent for their infant. This includes via natural birth, adoption, or surrogacy.
- EPDS score \>10 at eligibility screening.
You may not qualify if:
- Active alcohol or substance use disorder, mania or psychotic disorder (as these conditions are better managed in direct specialty care).
- Active suicide plan or intent (as emergent hospital-based care is likely required),
- Plan to move out of Ontario during the study.
- Unable to complete relevant study procedures and measures online. For the few participants without access to devices/home internet, we will budget for tablets/data plans.
- Unable to complete study activities in English. Note that Google translate is available for the intervention platform and language lines are available for participants so that they can be served in their language of choice, however we are unable to provide translations of all study assessment and questionnaire materials that participants will need to complete during the study.
- No primary care clinician (required for collaborative mental health care delivery model).
- Currently enrolled in a collaborative mental health care model.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Women's College Hospitallead
- Sunnybrook Health Sciences Centrecollaborator
- Mount Sinai Hospital, Canadacollaborator
- The Ottawa Hospitalcollaborator
- St. Joseph's Healthcare Hamiltoncollaborator
Study Sites (2)
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
Women's College Hospital
Toronto, Ontario, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2025
First Posted
July 15, 2025
Study Start
October 29, 2025
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
March 31, 2029
Last Updated
November 24, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share